News

Johnson & Johnson Pivots Its AI Strategy
The company is making a shift to focus on only the highest-value GenAI use cases and shut down pilots that were redundant or ...
4 Reasons Johnson & Johnson Could Be the Perfect Stock to Own in Today's Turbulent Market
Johnson & Johnson is increasing its dividend for the 63rd consecutive year. This further cements the healthcare giant's ...
Johnson & Johnson CEO warns US tariffs may disrupt drug supply
Johnson & Johnson Chief Executive Joaquin Duato said on Tuesday that tariffs on pharmaceuticals can create supply chain ...
Tariffs won’t boost U.S. manufacturing — tax cuts will, Johnson & Johnson CEO says
For medical-technology and pharmaceuticals manufacturing, “the most effective answer is not tariffs but tax policy,” Johnson ...
Johnson & Johnson expects $400 million in tariff-related costs, mostly related to China
Health care giant Johnson & Johnson expects about $400 million in tariff-related costs this year. The costs will be felt ...
Johnson & Johnson (JNJ) Is About to Report Its Q1 Earnings Tomorrow. Here Is What to Expect
Healthcare giant Johnson & Johnson (JNJ)is gearing up to release its first-quarter 2025 financials on April 15. JNJ stock has gained over ...
Johnson & Johnson price target raised to $169 from $164 at Morgan Stanley
Morgan Stanley raised the firm’s price target on Johnson & Johnson to $169 from $164 and keeps an Equal Weight rating on the shares after ...
Johnson & Johnson expects tariff costs to reach $400 million this year
Health care giant Johnson & Johnson expects about $400 million in tariff-related costs this year. The costs will be felt primarily within the company's medical technology unit, which makes a range of ...